Chemistry Reference
In-Depth Information
such as brain and liver. However, in these patients, as in aceruloplasminaemic mice, both copper transport
and metabolism are normal, providing strong evidence against the role of ceruloplasmin as a major copper
transporter.
REFERENCES
Altamura, S., & Muckenthaler, M. U. (2009). Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis.
The Journal of Alzheimer's Disease, 16, 879
e
895.
Barzilai, A., & Melamed, E. (2003). Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease. Trends in
Molecular Medicine, 9, 126
e
132.
Catala, A. (2009). Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physi-
ological and/or pathological conditions. Chemistry and Physics of Lipids, 157,1
e
11.
Crichton, R. R., & Ward, R. J. (2006). Metal based neurodegeneration: From molecular mechanisms to therapeutic strategies. Chichester:
John Wiley & Sons. pp. 227.
Dalle-Donne, I., Giustarini, D., Colombo, R., Rossi, R., & Milzani, A. (2003). Protein carbonylation in human diseases. Trends in Molecular
Medicine, 9, 164
e
176.
D¨rr, A. (2002). Friedreich's ataxia: treatment within reach. The Lancet Neurology, 1, 370
e
374.
Duce, J. A., & Bush, A. I. (2010). Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics. Progress in
Neurobiology, 92,1
e
18.
Rogers, J. T., Randall, J. D., Cahill, C. M., Eder, P. S., Huang, X., Gunshin, H., et al. (2002). An iron-responsive element type II in the 5'-
untranslated region of the Alzheimer's amyloid precursor protein transcript. The Journal of Biological Chemistry, 277, 45518
e
45528.
Ross, C. A., & Poirier, M. A. (2004). Protein aggregation and neurodegenerative disease. Nature Medicine, 10, S10
17.
Schneider, C., Porter, N. A., & Brash, A. R. (2008). Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation.
J Biol Chem., 283, 15539
e
43.
Shaw, B. F., & Valentine, J. S. (2007). How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein?
Trends in Biochemical Sciences, 32,78
e
85.
Zecca, L., Youdim, M. B., Riederer, P., Connor, J. R., & Crichton, R. R. (2004). Iron, brain ageing and neurodegenerative disorders. Nat. Rev.
Neurosci., 5, 863
e
873.
e
